Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological function

Bayley, 1996, Comparison of benzodiazepine BZ receptor agonists in two rodent activity tests, J. Psychopharmacol., 10, 206, 10.1177/026988119601000305 Bunzow, 1994, Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not μ, δ or κ opioid receptor type, FEBS Lett., 347, 284, 10.1016/0014-5793(94)00561-3 Calo, 2000, Pharmacology of nociceptin and its receptor: a novel therapeutic target, Br. J. Pharmacol., 129, 1261, 10.1038/sj.bjp.0703219 Carter, 1999, Characterisation of progressive motor deficits in mice transgenic for the human Huntington's disease mutation, J. Neurosci., 19, 3248, 10.1523/JNEUROSCI.19-08-03248.1999 Champion, 1997, Nociceptin: an endogenous ligand for the ORL1 receptor has novel hypotensive activity in the rat, Life Sci., 60, PL241, 10.1016/S0024-3205(97)00087-8 Chen, 1994, Molecular cloning, tissue distribution and chromasomal localization of a novel member of the opioid receptor gene family, FEBS Lett., 347, 279, 10.1016/0014-5793(94)00560-5 Civelli, 1999, Orphan receptors, novel neuropeptides and reverse pharmaceutical research, Brain Res., 848, 63, 10.1016/S0006-8993(99)02041-7 Connor, 1990, Cardiovascular effects of 5-HT1A receptor agonists injected into the dorsal raphe nucleus of conscious rats, Eur. J. Pharmacol., 182, 63, 10.1016/0014-2999(90)90493-P Darland, 1998, Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more, TINS, 21, 215 DeRyck, 1980, Morphine versus haloperidol catalepsy in the rat: a behavioural analysis of postural support systems, Brain Res., 201, 143, 10.1016/0006-8993(80)90781-7 Devine, 1996, The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion, Brain Res., 727, 225, 10.1016/0006-8993(96)00476-3 Florin, 1996, Nociceptin stimulates locomotion and exploratory behaviour in mice, Eur. J. Pharmacol., 317, 9, 10.1016/S0014-2999(96)00707-8 Fukuda, 1994, cDNA cloning and regional distribution of a novel member of the opioid receptor family, FEBS Lett., 343, 42, 10.1016/0014-5793(94)80603-9 Gerlai, 1996, Gene-targetting studies of mammalian behaviour: is it the mutation or the background genotype?, TINS, 19, 177 Griebel, 1999, Orphanin FQ, a novel neuropeptide with anti-stress-like activity, Brain Res., 836, 221, 10.1016/S0006-8993(99)01684-4 Henderson, 1997, The orphan opioid receptor and its endogenous ligand-nociceptin/orphanin FQ, TIPS, 18, 293 Hiramatsu, 1999, Effects of nocistatin on nociceptin-induced impairment of learning and memory in mice, Eur. J. Pharmacol., 367, 151, 10.1016/S0014-2999(99)00003-5 Houtani, 2000, Distribution of nociceptin/orphanin FQ precursor protein and receptor in brain and spinal cord: a study using in situ hybridisation and X-gal histochemistry in receptor-deficient mice, J. Comp. Neurol., 424, 489, 10.1002/1096-9861(20000828)424:3<489::AID-CNE7>3.0.CO;2-O Hunter, 2000, Functional assessments in mice and rats after focal stroke, Neuropharmacology, 39, 806, 10.1016/S0028-3908(99)00262-2 Ikeda, 1998, Distribution of prepro-nociceptin orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems, J. Comp. Neurol., 399, 139, 10.1002/(SICI)1096-9861(19980914)399:1<139::AID-CNE11>3.0.CO;2-C Irwin, 1968, Comprehensive and observational assessment: Ia. A systematic and quantitative procedure for assessing the behavioural and physiologic state of the mouse, Psychopharmacologia, 13, 222, 10.1007/BF00401402 Jenck, 1997, Orphanin FQ acts as an anxiolytic to attenuate behavioural responses to stress, PNAS, 94, 14854, 10.1073/pnas.94.26.14854 Jenck, 2000, A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat, PNAS, 97, 4938, 10.1073/pnas.090514397 Kapusta, 1999, Central administration of [Phe1psiCH2-NH.Gly2]nociceptin1-13-NH2 and orphanin FQ nociceptin OFQ/N produce similar cardiovascular and renal responses in concious rats, J. Pharmacol. Exp. Ther., 289, 173 Klemm, 1989, Drug effects on active immobility responses: what they tell us about neurotransmitter systems and motor functions, Prog. Neurobiol., 32, 403, 10.1016/0301-0082(89)90030-0 Madeddu, 1999, Cardiovascular effects of nociceptin in unanaesthetised mice, Hypertension, 33, 914, 10.1161/01.HYP.33.3.914 Manabe, 1998, Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors, Nature, 394, 577, 10.1038/29073 Marchese, 1999, Novel GPCRs and their endogenous ligands: expanding the boundaries of physiology and pharmacology, TIPS, 20, 370 Meunier, 1995, Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor, Nature, 377, 532, 10.1038/377532a0 Mollereau, 1994, ORL1, a novel member of the opioid receptor family — cloning, functional expression and localization, FEBS Lett., 341, 33, 10.1016/0014-5793(94)80235-1 Mollereau, 1996, Structure, tissue distribution, and chromasomal localization of the prepronociceptin gene, PNAS, 93, 8666, 10.1073/pnas.93.16.8666 Murphy, 1996, Intracerebroventricular orphanin FQ/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetised rats, Neuroscience, 75, 1, 10.1016/0306-4522(96)00322-3 Murphy, 1999, Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis, J. Neurochem., 73, 179, 10.1046/j.1471-4159.1999.0730179.x Neal, 1999, Localization of orphanin FQ nociceptin, peptide and messenger RNA in the central nervous system of the rat, J. Comp. Neurol., 406, 503, 10.1002/(SICI)1096-9861(19990419)406:4<503::AID-CNE7>3.0.CO;2-P Nishi, 1997, Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphanin FQ receptor, EMBO J., 16, 1858, 10.1093/emboj/16.8.1858 Noble, 1997, Association of aminopeptidase N and endopeptidase 24.15 inhibitors potentiate behavioural effects mediated by nociceptin/orphanin FQ in mice, FEBS Lett., 401, 227, 10.1016/S0014-5793(96)01476-7 Noda, 1998, Loss of antinociception induced by naloxone benzoylhydrazone in nociceptin receptor-knockout mice, J. Biol. Chem., 273, 18047, 10.1074/jbc.273.29.18047 Nothacker, 1996, Primary structure and tissue distribution of the orphanin FQ precursor, PNAS, 93, 8677, 10.1073/pnas.93.16.8677 Pomonis, 1996, Orphanin FQ, agonist of orphan receptor ORL1, stimulates feeding in rats, Neuroreport, 8, 369, 10.1097/00001756-199612200-00072 Reinscheid, 1995, Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor, Science, 270, 792, 10.1126/science.270.5237.792 Sanberg, 1988, The catalepsy test: its ups and downs, Behav. Neurosci., 102, 748, 10.1037/0735-7044.102.5.748 Sandin, 1997, Nociceptin orphanin FQ microinjected into hippocampus impairs spatial learning in rats, Eur. J. Neurosci., 9, 194, 10.1111/j.1460-9568.1997.tb01367.x Stratford, 1997, Injections of nociceptin into nucleus accumbens shell or ventromedial hypothalamic nucleus increase food intake, Neuroreport, 8, 423, 10.1097/00001756-199701200-00009 Sulaiman, 1999, Modulation of vestibular function by nociceptin/orphanin FQ: an in vivo and in vitro study, Brain Res., 828, 74, 10.1016/S0006-8993(99)01331-1 Tupper, 1980, Utility of the neurological examination in rats, Acta Neurobiol. Exp., 40, 999 Wang, 1994, cDNA cloning of an orphan opiate receptor gene family member and its splice variant, FEBS Lett., 348, 75, 10.1016/0014-5793(94)00557-5 Wichmann, 2000, Synthesis of 1S,3aS-8-2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one, a potent and selective orphanin FQ OFQ. receptor agonist with anxiolytic-like properties, Eur. J. Med. Chem., 35, 839, 10.1016/S0223-5234(00)00171-9 Wilson, 1998, Orphan G-protein-coupled receptors: the next generation of drug targets?, Br. J. Pharmacol., 125, 1387, 10.1038/sj.bjp.0702238